Argyle Closes C$500,000 LIFE Offering
aTyr PharmaaTyr Pharma(US:LIFE) Newsfile·2025-10-31 10:00

Core Points - Argyle Resources Corp. has successfully closed an offering of units at a price of C$0.20 per unit, raising aggregate gross proceeds of C$500,000 [1] - Each unit consists of one common share and one share purchase warrant, with the warrant allowing the purchase of one share at an exercise price of C$0.27 for 24 months [1] - The offering was conducted under the listed issuer financing exemption, meaning the units are not subject to resale restrictions [2] Financial Details - The total cash fees paid to finders for their services amounted to C$16,800, along with the issuance of 84,000 broker warrants, each exercisable at C$0.27 for 24 months [3] - The net proceeds from the offering will be allocated for legal and accounting expenses, marketing, mineral property exploration, and general working capital [4] Company Overview - Argyle Resources Corp. is a junior mineral exploration company focused on acquiring and evaluating natural resource properties in North America [6] - The company holds a 100% interest in several silica projects in Québec and has options to acquire additional properties in Ontario and Nova Scotia [6] - Argyle is collaborating with the National Institute of Scientific Research to conduct exploration programs on its silica projects [6]